COMPARATIVE ANALYSIS OF LABORATORY INDICATORS IN COVID-19 PATIENTS WITH AND WITHOUT CANCER DISEASES IN THE RESUSCITATION AND INTENSIVE CARE DEPARTMENT
Abstract and keywords
Abstract (English):
In COVID-19 patients with cancer diseases multi-organ failure develops more frequently than in patients without cancer pathologies. This condition is characterized by disorders of functions of several organs or systems at once, which sufficiently worsens the prognosis for recovery.

Keywords:
COVID-19, cancer diseases, general blood analysis, biochemical blood analysis
Text
Text (PDF): Read Download
References

1. Huang C., Wang Y., Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. // Lancet. – 2020; 395(10223):497-506. Doi:https://doi.org/10.1016/S0140-6736(20)30183-5

2. Guan W.J., Ni Z.Y., Hu Y. et al. Clinical Characteristics of Coronavirus Disease 2019 in China // N Engl J Med. – 2020; 382(18):1708-1720. Doi:https://doi.org/10.1056/NEJMoa2002032

3. Zhang H., Cao X., Kong M. et al. Clinical and hematological characteristics of 88 patients with COVID-19 // Int J Lab Hematol. – 2020; 42(6):780-787. Doi:https://doi.org/10.1111/ijlh.13291

4. Frater J.L., Zini G., d’Onofrio G., Rogers H.J. COVID-19 and the clinical hematology laboratory // Int J Lab Hematol. – 2020; 42 Suppl 1(Suppl 1):11-18. Doi:https://doi.org/10.1111/ijlh.13229

5. Curigliano G., Banerjee S., Cervantes A. et al. Panel members. Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus // Ann Oncol. – 2020; 31(10):1320–35. https://doi.org/10.1016/j.annonc.2020.07.010

6. Vehreschild J.J., Stecher M., Schons M. (2020) [cited 2020 04.10.2020]; Available from: https://leoss.net

7. Ruan Q., Yang K., Wang W., Jiang L., Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China // Intensive Care Med. – 2020; 46:846–848. Doi:https://doi.org/10.1007/s00134-020-05991-x

8. Zanza C., Romenskaya T., Manetti A.C., Franceschi F., La Russa R., Bertozzi G., Maiese A., Savioli G., Volonnino G., Longhitano Y. Cytokine Storm in COVID-19: Immunopathogenesis and Therapy // Medicina (Kaunas). – 2022 Jan 18; 58(2):144. Doi:https://doi.org/10.3390/medicina58020144

9. Dinarello C.A. Why not treat human cancer with interleukin-1 blockade? // Cancer Metastasis Rev. – 2010; 29(2):317–329.

10. de Jesus A.A. et al. Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling // Annu Rev Immunol Dinarello C.A. Why not treat human cancer with interleukin-1 blockade? // Cancer Metastasis Rev. – 2010; 29:317–329. 2015; 33:823-874.

11. Wang Q., Berger N.A., Xu R. (2020). Analysis of hospitalized COVID-19 patients with cancer: a retrospective study of the impact of cancer on COVID-19 outcomes // Journal of Clinical Oncology, 38(33), 4183-4194. Doi:https://doi.org/10.1200/JCO.20.02726

12. Kotenko K.V., Frolkov V.K., Nagornev S.N., Korchazhkina N.B., Gusakova E.V., Chelombit'ko E.G. Perspektivy primeneniya pit'evyh mineral'nyh vod v reabilitacii pacientov s koronavirusnoy (COVID-19) infekciey: analiz osnovnyh sanogeneticheskih mehanizmov // Voprosy kurortologii, fizioterapii i lechebnoy fizicheskoy kul'tury. – 2021. – T. 98. – № 6–2. – S. 75–84.

13. Cyganova T.N., Frolkov V.K., Korchazhkina N.B. Patogeneticheskoe obosnovanie primeneniya gipo-giperoksicheskoy trenirovki v lechenii i profilaktike oslozhneniy koronavirusnoy infekcii COVID-19 // Fizioterapevt. – 2021. – № 1. – S. 14–25.

14. Razumov A.N., Ponomarenko G.N., Badtieva V.A., Ezhov V.V., Kaladze N.N., Kovlen D.V., Korchazhkina N.B., Pogonchenkova I.V. Medicinskaya reabilitaciya pacientov, perenesshih COVID-19, v sanatorno-kurortnyh organizaciyah / Metodicheskie rekomendacii // Sankt-Peterburg. – 2021.

15. Abbasi B., Amjad H., Mark L., Ananya G., Sanjeev G. Serum protein and electrolyte imbalances are associated with chemotherapy induced neutropenia // Heliyon, Volume 8, Issue 7, 2022. e09949, ISSN 2405-8440. https://doi.org/10.1016/j.heliyon.2022.e09949

Login or Create
* Forgot password?